IDEXX Labs (IDXX) Tops Q4 EPS by 14c, Revenues Beat; Raises FY20 EPS/Revenue Guidance
Go back to IDEXX Labs (IDXX) Tops Q4 EPS by 14c, Revenues Beat; Raises FY20 EPS/Revenue Guidance| Idexx Laboratories, Inc. (NASDAQ: IDXX) | Delayed: 545.56 -16.53 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $562.09 | 52 Week High | $117.84 | |||
| Open | $555.92 | 52 Week Low | $63.48 | |||
| Day High | $562.74 | P/E | 156.77 | |||
| Day Low | $540.99 | EPS | $3.48 | |||
| Volume | 327,718 | |||||
